volume 357 issue 3

Nascent pharmacological advancement in adamantane derivatives

Publication typeJournal Article
Publication date2023-12-21
scimago Q2
wos Q2
SJR0.571
CiteScore7.0
Impact factor3.6
ISSN03656233, 15214184
Drug Discovery
Pharmaceutical Science
Abstract

The adamantane moiety has attracted significant attention since its discovery in 1933 due to its remarkable structural, chemical, and medicinal properties. This molecule has a notable impact in the therapeutic field because of its “add‐on” lipophilicity to any pharmacophoric moieties. As in the case of molecular hybridization, in which one pharmacophore is attached to another one(s) with a probability of increasing the biological activity, adding an adamantane unit improves the absorption distribution, metabolism and excretion properties of the resultant hybrid molecule. This review summarizes various reports highlighting the biological activities of adamantane‐based synthetic compounds and their structure–activity relationship study. The information presented in this review may open up possible dimensions for adamantane‐based drug development and discovery in the pharmaceutical industry after proper structural modifications.

Found 
Found 

Top-30

Journals

1
2
3
International Journal of Biological Macromolecules
3 publications, 15%
Journal of the American Chemical Society
2 publications, 10%
Frontiers in Chemistry
1 publication, 5%
Pharmacokinetics and Pharmacodynamics (Farmakokinetika i farmakodinamika)
1 publication, 5%
Australian Journal of Chemistry
1 publication, 5%
Journal of Molecular Structure
1 publication, 5%
Journal of Molecular Liquids
1 publication, 5%
Organic and Biomolecular Chemistry
1 publication, 5%
Chemistry
1 publication, 5%
European Journal of Medicinal Chemistry
1 publication, 5%
Archiv der Pharmazie
1 publication, 5%
Journal of Computer-Aided Molecular Design
1 publication, 5%
ChemMedChem
1 publication, 5%
Chem
1 publication, 5%
Russian Chemical Bulletin
1 publication, 5%
Bioorganic Chemistry
1 publication, 5%
Molecular Diversity
1 publication, 5%
1
2
3

Publishers

1
2
3
4
5
6
7
8
Elsevier
8 publications, 40%
Springer Nature
3 publications, 15%
American Chemical Society (ACS)
2 publications, 10%
Wiley
2 publications, 10%
Frontiers Media S.A.
1 publication, 5%
Publishing House OKI
1 publication, 5%
CSIRO Publishing
1 publication, 5%
Royal Society of Chemistry (RSC)
1 publication, 5%
MDPI
1 publication, 5%
1
2
3
4
5
6
7
8
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
20
Share
Cite this
GOST |
Cite this
GOST Copy
Ragshaniya A. et al. Nascent pharmacological advancement in adamantane derivatives // Archiv der Pharmazie. 2023. Vol. 357. No. 3.
GOST all authors (up to 50) Copy
Ragshaniya A., Kumar V., Tittal R. K., Lal K. Nascent pharmacological advancement in adamantane derivatives // Archiv der Pharmazie. 2023. Vol. 357. No. 3.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/ardp.202300595
UR - https://doi.org/10.1002/ardp.202300595
TI - Nascent pharmacological advancement in adamantane derivatives
T2 - Archiv der Pharmazie
AU - Ragshaniya, Aman
AU - Kumar, Vijay
AU - Tittal, Ram K.
AU - Lal, Kashmiri
PY - 2023
DA - 2023/12/21
PB - Wiley
IS - 3
VL - 357
PMID - 38128028
SN - 0365-6233
SN - 1521-4184
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Ragshaniya,
author = {Aman Ragshaniya and Vijay Kumar and Ram K. Tittal and Kashmiri Lal},
title = {Nascent pharmacological advancement in adamantane derivatives},
journal = {Archiv der Pharmazie},
year = {2023},
volume = {357},
publisher = {Wiley},
month = {dec},
url = {https://doi.org/10.1002/ardp.202300595},
number = {3},
doi = {10.1002/ardp.202300595}
}